Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Multicare Deaconess launches ED pilot offering long‑acting injectable buprenorphine to protect patients from overdose
Summary
Multicare’s Deaconess emergency department began a pilot in February giving long‑acting injectable buprenorphine (Brixadi) to patients with opioid use disorder; staff said 11 injections were given so far, community partners provide follow‑up care, and the approach aims to improve retention and reduce overdoses.
Sarah Welty, nurse care manager for Multicare’s medication for opioid use disorder team, described a Deaconess emergency‑department pilot that began Feb. 3 offering a long‑acting injectable formulation of buprenorphine (Brixadi) to patients who meet clinical criteria.
Welty said the injectable provides five to seven days of coverage from a single dose and that subsequent community follow‑up injections can extend coverage to a…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
